Skip to main content

Modifications of coagulation imbalance during antithrombin treatment in preeclamptic patients: our experience

Introduction

Preeclamptic conditions are often associated with a natural inhibitor consumption. Many studies have evidenced validity of antithrombin (AT) treatment during preeclamptic conditions. The aim of the study is to restore a congruous coagulation imbalance with administration of AT under the guide of thromboelastographic monitoring (TEG).

Methods

Ten preeclamptic pregnant women in the 24th–30th weeks with diastolic blood pressure >90 mmHg and urinary protein level 24 hours >0.3 g were included. All patients were submitted to a complete study of coagulation function: prothrombin time (PT), activated partial thromboplastin time (aPTT), International Normalization Ratio (INR), fibrinogen C, D-dimer, AT and TEG at the beginning, after every administration of AT, weekly until caesarean section, and daily for 1 week in the postoperative period. AT was administered every time the AT plasmatic level was less than 80% to restore the plasmatic level to more than 120% using the following algorithm: (120% - AT plasmatic level) × kg. At the beginning, only seven patients were treated with AT.

Results

At the beginning, all patients showed AT consumption and a hypercoagulation TEG (Figure 1), but the INR and aPTT were in the normal ranges. Patients treated with AT at the beginning did not need a new administration. The remaining patients were treated at the 31st, 33rd and 34th weeks, respectively. In all patients, AT administration determined a normalization of TEG without any modification of the PT and aPTT or bleeding. All patients were submitted to caesarean section between the 36th and 39th weeks.

Figure 1
figure1

Thromboelastographic monitoring at admission.

Conclusion

AT administration could play a central role in preeclampsia treatment. TEG monitoring evidenced, in real time, coagulation changes that common laboratory tests could not show.

References

  1. 1.

    Redman C: Am J Obstet Gynecol. 1999, 180: 499-506. 10.1016/S0002-9378(99)70239-5

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Buscemi, C., Pirri, S., Mangione, D. et al. Modifications of coagulation imbalance during antithrombin treatment in preeclamptic patients: our experience. Crit Care 12, P213 (2008). https://doi.org/10.1186/cc6434

Download citation

Keywords

  • Caesarean Section
  • Fibrinogen
  • Preeclampsia
  • International Normalization Ratio
  • Prothrombin Time